MedicNest.euLive Grid

bt_bb_section_bottom_section_coverage_image

Dates: 01/06/2021 31/05/2028 Topic: Procedures Project type: Clinic Project target: Infectious disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM Keywords: tuberculosis; drug resistance; machine learning; microbiology; simulation software; tool; procedure; clinical trial; biomarker Countries: Netherlands; UK;...

Dates: 01/01/2020 31/12/2024 Topic: Biomarkers identification Project type: Preclinic Clinic Project target: Digestive disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: HUMANITAS UNIVERSITY Keywords: bowel disease; biomarker; dermatitis; ulcerative colitis; liquid biopsy; OMICs; IMID Countries: Italy; Austria; Germany; UK; Netherlands; Belgium;...

Dates: 01/07/2021 30/06/2026 Topic: Biomarkers identification Tool AI/Big Data Project type: Preclinic Clinic Project target: Autoimmune disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: UNIVERSITY COLLEGE DUBLIN; NATIONAL UNIVERSITY OF IRELAND; DUBLIN Keywords: psoriasis; arthritis; autoimmunity; skin; drug discovery; machine learning;...

Dates: 01/01/2019 31/12/2024 Topic: Biomarkers identification Project type: Clinic Preclinic Project target: Autoimmune disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE Keywords: Countries: France; UK; Sweden; Netherlands; Spain; Greece; Ireland; Norway;...

Dates: 01/05/2020 30/04/2025 Topic: Biomarkers identification AI/Big data Project type: Preclinic Theranostic Project target: Cancer Neurology Digestive disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN Keywords: biomarker; drug; library; genome; neurodegeneration; cancer; bowel disease; solute...

Dates: 01/01/2020 31/12/2024 Topic: Biomarkers identification Strategies Project type: Preclinic Clinic Project target: Infectious disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.3. – Treating and managing disease Participating agents: CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES Keywords: hospital-acquired pneumonia; pneumonology; antibiotic; infectious disease; drug resistance; biomarker; strategy; OMICs; clinical trial; procedure Countries:...

Dates: 01/09/2021 31/08/2026 Topic: Tool Project type: Preclinic Medical Device Project target: Cardiovascular disease Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: UNIVERSITA DEGLI STUDI DI PADOVA ACADEMISCH ZIEKENHUIS LEIDEN – LEIDS UNIVERSITAIR MEDISCH CENTRUM Keywords: stem cell; tissue engineering; cardiac arrhythmia; heart Countries: Italy; Netherlands Project page: Access page  

Dates: 01/02/2020 31/01/2025 Topic: Tool AI/Big Data Biomarkers identification Project type: Preclinic Project target: Neurology Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: UNIVERSITAIR MEDISCH CENTRUM UTRECHT Keywords: vascular disease; aneurysm; brain; subarachnoid haemorrhage; machine learning; imaging marker Countries: Netherlands Project page: Access page  

Dates: 01/06/2018 31/05/2023 Topic: Biomarkers identification Procedures Project type: Preclinic Clinic Project target: Neurology Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being MAIN PROGRAMME H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: KING’S COLLEGE LONDON Keywords: Autism Spectrum Disorder; clinical trial; biomarker; procedures; network; consortium Countries: UK; Switzerland; Netherlands; Spain;...

Dates: 01/01/2020 31/12/2023 Topic: Biomarkers identification Project type: Immunotherapy Project target: Autoimmune disease Infectious disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.3. – Treating and managing disease Participating agents: Radboud University Medical Center -ELLINIKO INSTITUTO MELETIS TIS SIPSIS -CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS -UNIVERSITATSKLINIKUM JENA -ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT...